FDA Warning Letter — PREMIUM NATURE
The FDA took a Warning Letter action against PREMIUM NATURE on Sep 1, 2022 (South Plainfield, NJ). The action was issued by CDER and concerns drugs products.
Action details
- Facility
- PREMIUM NATURE
- Date
- Sep 1, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Center
- CDER
- Location
- South Plainfield, NJ (United States)